InvestorsHub Logo
Post# of 252489
Next 10
Followers 832
Posts 119978
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 193725

Wednesday, 09/23/2015 10:13:31 AM

Wednesday, September 23, 2015 10:13:31 AM

Post# of 252489
Announced FoB Collaborations

[Updates re AMGN-AGN collaboration.]


Items are shown in reverse chronological order. This table does not purport to be exhaustive.


Date Targets Geography iHub References

AZN-Fujifilm/Kyowa 7/15 Avastin global #msg-115666552
PFE(HSP)-PFNX 2/15 Lucentis global #msg-110725481
Merck KGaA-Hanwha 2/15 Enbrel ex-US #msg-110668714
EPRS-Livzon 9/14 5 mAbs China #msg-106600322
NeuClone-Serum Inst 7/14 10 mAbs global #msg-104136710
Liomont-Oncobiolgcs 6/14 2 mAbs Mexico #msg-103754486
PlantForm-PhrmaPrxs 6/14 Avastin Brazil #msg-103576633
Lupin-Yoshindo 4/14 Enbrel Japan #msg-101018361
EPRS-Ranbaxy 1/14 Remicade Asia/Africa #msg-95745192
BXLT-CHRS 9/13 Enbrel ex-US #msg-91645674
Oncobiolgcs-Huahai 5/13 # global #msg-87734336,#msg-87744882
Strides-Pfenex 4/13 Betaseron global #msg-87014470
MRK-Samsng/BIIB 2/13 @ @ #msg-114478003,#msg-84781042,#msg-69629103
Catalent-UMN 12/12 various Asia #msg-82556713
Merck KGaA-RDY 6/12 oncology global #msg-76359649
Daiichi-CHRS 5/12 Enbrel Asia #msg-75397629
Fujifilm-Kyowa 3/12 Humira unspecified #msg-73800486
AGN-Bioton 2/12 insulin US & Europe #msg-74987123
AGN-AMGN 12/11 † global #msg-70097496,#msg-117190738
BXLT-MNTA 12/11 Humira global #msg-110925786
PFE(HSP)-Celltrion 10/09 z global #msg-84519981,#msg-77816122
MYL-Biocon 6/09 x global #msg-72421544,#msg-84561737
Procognia-UTR n/a Humira unspecified #msg-84340976

†Herceptin, Avastin, Rituxan, Erbitux; AMGN working independently on Humira and Remicade.

@ Enbrel [worldwide except US/EU/Japan], Remicade [worldwide except EU/Russia/Turkey], Humira [worldwide except EU/Russia/Turkey], Herceptin [worldwide], Lantus [worldwide].

#Humira, Rituxan, Avastin, Herceptin.

x Nine products: Herceptin, Neulasta, Avastin, Humira, Enbrel, Lantus, Novolog, Humalog, one undisclosed.

z Each company received a distinct EU/CHMP approval for Remicade on 6/28/13; partnership includes seven (other) products: Rituxan, Herceptin, Enbrel, Erbitux, Synagis, Humira, Avastin.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.